Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
R.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ML.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.283NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.96NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
L.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.310NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.185NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.329NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.229NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.342NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.90NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.169NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.513NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.338NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.284NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.498NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.184NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.187NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.139NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.508NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.94NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.357NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.318NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.557NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.119NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.160NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.134NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.381NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.526NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.279NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.201NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.221NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used